Phase 1b study of first-line Ramucirumab plus Platinum plus Fluoropyrimidine in Japanese Patients with advanced gastric cancer

被引：0
|
作者：
Kadowaki, Shigenori [1 ]
Shitara, Kohei [2 ]
Sakai, Daisuke [3 ]
Nishina, Tomohiro [4 ]
Yoshikawa, Reigetsu [5 ]
Piao, Yongzhe [5 ]
Ozeki, Akichika [5 ]
Inoue, Koichi [5 ]
Muro, Kei [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Osaka Univ Hosp, Osaka, Japan
[4] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[5] Eli Lilly Japan KK, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3 - 9 - 4
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
    Chu, Tianqing
    Zhong, Runbo
    Zhong, Hua
    Zhang, Bo
    Zhang, Wei
    Shi, Chunlei
    Qian, Jialin
    Zhang, Yanwei
    Chang, Qing
    Zhang, Xueyan
    Dong, Yu
    Teng, Jiajun
    Gao, Zhiqiang
    Qiang, Huiping
    Nie, Wei
    Zhao, Yiming
    Han, Yuchen
    Chen, Ya
    Han, Baohui
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : 643 - 652
  • [2] Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric cancer who previously treated with first-line nivolumab plus chemotherapy
    Jeon, Youngkyung
    Jeong, Sun Young
    Jang, Jaeyeon
    Jung, Ye Ji
    Choi, Daeho
    Hong, Joohyun
    Kim, Seung Tae
    Kang, Won Ki
    Lee, Jeeyun
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [3] Randomized phase 1b/3 study of erlotinib plus ramucirumab in first-line EGFR mut 1 stage IV NSCLC: phase 1b safety results
    Nakagawa, K.
    Garon, E. B.
    Paz-Ares, L.
    Ponce, S.
    Corral Jaime, J.
    Juan Vidal, O.
    Nadal, E.
    Kiura, K.
    He, S.
    Treat, J.
    Dalal, R.
    Lee, P.
    Reck, M.
    Novello, S.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma
    Ooki A.
    Satoh T.
    Muro K.
    Takashima A.
    Kadowaki S.
    Sakai D.
    Ichimura T.
    Mitani S.
    Kudo T.
    Chin K.
    Kitano S.
    Thai D.
    Zavodovskaya M.
    Liu J.J.
    Boku N.
    Yamaguchi K.
    [J]. Scientific Reports, 12 (1)
  • [5] Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
    Kito, Yosuke
    Satake, Hironaga
    Taniguchi, Hiroya
    Yamada, Takeshi
    Horie, Yoshiki
    Esaki, Taito
    Denda, Tadamichi
    Yasui, Hisateru
    Izawa, Naoki
    Masuishi, Toshiki
    Moriwaki, Toshikazu
    Mori, Keita
    Yamazaki, Kentaro
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (02) : 277 - 284
  • [6] Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
    Yosuke Kito
    Hironaga Satake
    Hiroya Taniguchi
    Takeshi Yamada
    Yoshiki Horie
    Taito Esaki
    Tadamichi Denda
    Hisateru Yasui
    Naoki Izawa
    Toshiki Masuishi
    Toshikazu Moriwaki
    Keita Mori
    Kentaro Yamazaki
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 86 : 277 - 284
  • [7] A multicenter phase II study of S-1 plus ramucirumab as first-line treatment in elderly patients with advanced/recurrent gastric cancer (KSCC1701).
    Katsuya, Hiroo
    Suyama, Koichi
    Kobayashi, Kazuma
    Izawa, Naoki
    Uenosono, Yoshikazu
    Hu, Qingjiang
    Kusumoto, Tetsuya
    Otsu, Hajime
    Orita, Hiroyuki
    Kawanaka, Hirofumi
    Shibao, Kazunori
    Koga, Satoshi
    Shimokawa, Mototsugu
    Makiyama, Akitaka
    Saeki, Hiroshi
    Oki, Eiji
    Baba, Hideo
    Mori, Masaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [9] A phase Ⅱ trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    YANG Lin
    SONG Yan
    ZHOU Ai-ping
    QIN Qiong
    CHI Yihebali
    HUANG Jing
    WANG Jin-wan
    [J]. 中华医学杂志(英文版), 2013, 126 (18) : 3470 - 3474
  • [10] A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer
    Xiang, Xiao Jun
    Zhang, Ling
    Qiu, Feng
    Yu, Feng
    Zhan, Zheng Yu
    Feng, Miao
    Yan, Jun
    Zhao, Jian Guo
    Xiong, Jian Ping
    [J]. CHEMOTHERAPY, 2012, 58 (01): : 1 - 7
12345